Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Som meddelt i Selskabsmeddelelse nr. 03/2022 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner.Programmet begyndte den 21. februar 2022 og slutter senest den 19. august 2022. ...
-
As mentioned in Announcement no. 03/2022 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.The programme commenced on 21 February 2022 and will end no later than 19...
-
Se venligst vedlagte pdf. Vedhæftet fil 31032022_handel_med_aktier_NAN ...
-
Please see enclosed pdf. Attachment 31032022_trading_in_shares_NAN ...
-
Se venligst vedlagte pdf. Vedhæftet fil 31032022_handel_med_aktier_ARA ...
-
Please see enclosed pdf. Attachment 31032022_trading_in_shares_ARA ...
-
Som meddelt i Selskabsmeddelelse nr. 03/2022 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner.Programmet begyndte den 21. februar 2022 og slutter senest den 19. august 2022. ...
-
As mentioned in Announcement no. 03/2022 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.The programme commenced on 21 February 2022 and will end no later than 19...
-
The randomized cross-over clinical trial assessed the new Provox® Life™ System for pulmonary rehabilitation and quality of life after total laryngectomy. A clinical study1 funded by...
-
As mentioned in Announcement no. 03/2022 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.The programme commenced on 21 February 2022 and will end no later than 19...